Back to search
FDAFDA · Food and drugs·Recall number D-0085-2025

ZoomMax Capsules, 500 mg, 10 count blisters in cartons, Distributed by: ZoomMax, 2108 N St. Sacramento, CA 95816, www.zoommax.com

Published December 11, 2024 · Recall initiated: November 4, 2024

Summary

FDA records drug Class I recall D-0085-2025, published December 11, 2024 and initiated November 4, 2024. Recalling firm: Boulla LLC; Status: Ongoing; Reported quantity: Unknown; Lot: Lot #: YZM240406, Exp: 04/05/2027. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Boulla LLC
Distributor
Nationwide within the United States
Lot
Lot #: YZM240406, Exp: 04/05/2027
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was ZoomMax Capsules, 500 mg, 10 count blisters in cartons, Distributed by: ZoomMax, 2108 N St. Sacramento, CA 95816, www.zoommax.com recalled?

Yes. FDA published recall D-0085-2025 on December 11, 2024. Reported hazard: Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail